Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Neuromyelitis Optica Spectrum Disorder (NMOSD) market size was valued at US$ million in 2023. With growing demand in downstream market, the Neuromyelitis Optica Spectrum Disorder (NMOSD) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Neuromyelitis Optica Spectrum Disorder (NMOSD) market. Neuromyelitis Optica Spectrum Disorder (NMOSD) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Neuromyelitis Optica Spectrum Disorder (NMOSD). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Neuromyelitis Optica Spectrum Disorder (NMOSD) market.
Neuromyelitis optica spectrum disorder (NMOSD), also known as Devic disease, is a chronic disorder of the brain and spinal cord dominated by inflammation of the optic nerve (optic neuritis) and the spinal cord (myelitis). Classically, it was felt to be a monophasic illness, consisting of episodes of inflammation of one or both optic nerves and the spinal cord over a short period of time (days or weeks) but, after the initial episode, no recurrence. It is now recognized that most patients satisfying current criteria for NMOSD experience repeated attacks separated by periods of remission. The interval between attacks may be weeks, months or years.
Key Features:
The report on Neuromyelitis Optica Spectrum Disorder (NMOSD) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Neuromyelitis Optica Spectrum Disorder (NMOSD) market. It may include historical data, market segmentation by Type (e.g., Intravenous, Oral), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Neuromyelitis Optica Spectrum Disorder (NMOSD) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Neuromyelitis Optica Spectrum Disorder (NMOSD) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Neuromyelitis Optica Spectrum Disorder (NMOSD) industry. This include advancements in Neuromyelitis Optica Spectrum Disorder (NMOSD) technology, Neuromyelitis Optica Spectrum Disorder (NMOSD) new entrants, Neuromyelitis Optica Spectrum Disorder (NMOSD) new investment, and other innovations that are shaping the future of Neuromyelitis Optica Spectrum Disorder (NMOSD).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Neuromyelitis Optica Spectrum Disorder (NMOSD) market. It includes factors influencing customer ' purchasing decisions, preferences for Neuromyelitis Optica Spectrum Disorder (NMOSD) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Neuromyelitis Optica Spectrum Disorder (NMOSD) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Neuromyelitis Optica Spectrum Disorder (NMOSD) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Neuromyelitis Optica Spectrum Disorder (NMOSD) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Neuromyelitis Optica Spectrum Disorder (NMOSD) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Neuromyelitis Optica Spectrum Disorder (NMOSD) market.
Market Segmentation:
Neuromyelitis Optica Spectrum Disorder (NMOSD) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Neuromyelitis Optica Spectrum Disorder (NMOSD) market size was valued at US$ million in 2023. With growing demand in downstream market, the Neuromyelitis Optica Spectrum Disorder (NMOSD) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Neuromyelitis Optica Spectrum Disorder (NMOSD) market. Neuromyelitis Optica Spectrum Disorder (NMOSD) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Neuromyelitis Optica Spectrum Disorder (NMOSD). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Neuromyelitis Optica Spectrum Disorder (NMOSD) market.
Neuromyelitis optica spectrum disorder (NMOSD), also known as Devic disease, is a chronic disorder of the brain and spinal cord dominated by inflammation of the optic nerve (optic neuritis) and the spinal cord (myelitis). Classically, it was felt to be a monophasic illness, consisting of episodes of inflammation of one or both optic nerves and the spinal cord over a short period of time (days or weeks) but, after the initial episode, no recurrence. It is now recognized that most patients satisfying current criteria for NMOSD experience repeated attacks separated by periods of remission. The interval between attacks may be weeks, months or years.
Key Features:
The report on Neuromyelitis Optica Spectrum Disorder (NMOSD) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Neuromyelitis Optica Spectrum Disorder (NMOSD) market. It may include historical data, market segmentation by Type (e.g., Intravenous, Oral), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Neuromyelitis Optica Spectrum Disorder (NMOSD) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Neuromyelitis Optica Spectrum Disorder (NMOSD) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Neuromyelitis Optica Spectrum Disorder (NMOSD) industry. This include advancements in Neuromyelitis Optica Spectrum Disorder (NMOSD) technology, Neuromyelitis Optica Spectrum Disorder (NMOSD) new entrants, Neuromyelitis Optica Spectrum Disorder (NMOSD) new investment, and other innovations that are shaping the future of Neuromyelitis Optica Spectrum Disorder (NMOSD).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Neuromyelitis Optica Spectrum Disorder (NMOSD) market. It includes factors influencing customer ' purchasing decisions, preferences for Neuromyelitis Optica Spectrum Disorder (NMOSD) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Neuromyelitis Optica Spectrum Disorder (NMOSD) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Neuromyelitis Optica Spectrum Disorder (NMOSD) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Neuromyelitis Optica Spectrum Disorder (NMOSD) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Neuromyelitis Optica Spectrum Disorder (NMOSD) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Neuromyelitis Optica Spectrum Disorder (NMOSD) market.
Market Segmentation:
Neuromyelitis Optica Spectrum Disorder (NMOSD) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Intravenous
- Oral
- Subcutaneous
- Others
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- F. Hoffmann-La Roche Ltd
- Alexion Pharmaceuticals
- RemeGen
- Nihon Pharmaceutical
- Harbour BioMed
- Lundbeck
- Bionure
- Opexa Therapeutics
- TG Therapeutics
- Bio-Thera Solutions
- Boston Pharmaceuticals
- Cour Pharmaceutical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2019-2030
2.1.2 Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Neuromyelitis Optica Spectrum Disorder (NMOSD) Segment by Type
2.2.1 Intravenous
2.2.2 Oral
2.2.3 Subcutaneous
2.2.4 Others
2.3 Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Type
2.3.1 Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Type (2019-2024)
2.4 Neuromyelitis Optica Spectrum Disorder (NMOSD) Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Application
2.5.1 Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Application (2019-2024)
3 NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD) MARKET SIZE BY PLAYER
3.1 Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Players
3.1.1 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue by Players (2019-2024)
3.1.2 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue Market Share by Players (2019-2024)
3.2 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD) BY REGIONS
4.1 Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Regions (2019-2024)
4.2 Americas Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth (2019-2024)
4.3 APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth (2019-2024)
4.4 Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth (2019-2024)
4.5 Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Country (2019-2024)
5.2 Americas Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Type (2019-2024)
5.3 Americas Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Region (2019-2024)
6.2 APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Type (2019-2024)
6.3 APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) by Country (2019-2024)
7.2 Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Type (2019-2024)
7.3 Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) by Region (2019-2024)
8.2 Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Type (2019-2024)
8.3 Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD) MARKET FORECAST
10.1 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Forecast by Regions (2025-2030)
10.1.1 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Forecast by Regions (2025-2030)
10.1.2 Americas Neuromyelitis Optica Spectrum Disorder (NMOSD) Forecast
10.1.3 APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Forecast
10.1.4 Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Forecast
10.1.5 Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Forecast
10.2 Americas Neuromyelitis Optica Spectrum Disorder (NMOSD) Forecast by Country (2025-2030)
10.2.1 United States Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.2.2 Canada Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.2.3 Mexico Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.2.4 Brazil Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.3 APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Forecast by Region (2025-2030)
10.3.1 China Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.3.2 Japan Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.3.3 Korea Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.3.4 Southeast Asia Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.3.5 India Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.3.6 Australia Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.4 Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Forecast by Country (2025-2030)
10.4.1 Germany Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.4.2 France Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.4.3 UK Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.4.4 Italy Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.4.5 Russia Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.5 Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Forecast by Region (2025-2030)
10.5.1 Egypt Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.5.2 South Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.5.3 Israel Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.5.4 Turkey Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.5.5 GCC Countries Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.6 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Forecast by Type (2025-2030)
10.7 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 F. Hoffmann-La Roche Ltd
11.1.1 F. Hoffmann-La Roche Ltd Company Information
11.1.2 F. Hoffmann-La Roche Ltd Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
11.1.3 F. Hoffmann-La Roche Ltd Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 F. Hoffmann-La Roche Ltd Main Business Overview
11.1.5 F. Hoffmann-La Roche Ltd Latest Developments
11.2 Alexion Pharmaceuticals
11.2.1 Alexion Pharmaceuticals Company Information
11.2.2 Alexion Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
11.2.3 Alexion Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Alexion Pharmaceuticals Main Business Overview
11.2.5 Alexion Pharmaceuticals Latest Developments
11.3 RemeGen
11.3.1 RemeGen Company Information
11.3.2 RemeGen Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
11.3.3 RemeGen Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 RemeGen Main Business Overview
11.3.5 RemeGen Latest Developments
11.4 Nihon Pharmaceutical
11.4.1 Nihon Pharmaceutical Company Information
11.4.2 Nihon Pharmaceutical Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
11.4.3 Nihon Pharmaceutical Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Nihon Pharmaceutical Main Business Overview
11.4.5 Nihon Pharmaceutical Latest Developments
11.5 Harbour BioMed
11.5.1 Harbour BioMed Company Information
11.5.2 Harbour BioMed Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
11.5.3 Harbour BioMed Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Harbour BioMed Main Business Overview
11.5.5 Harbour BioMed Latest Developments
11.6 Lundbeck
11.6.1 Lundbeck Company Information
11.6.2 Lundbeck Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
11.6.3 Lundbeck Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Lundbeck Main Business Overview
11.6.5 Lundbeck Latest Developments
11.7 Bionure
11.7.1 Bionure Company Information
11.7.2 Bionure Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
11.7.3 Bionure Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Bionure Main Business Overview
11.7.5 Bionure Latest Developments
11.8 Opexa Therapeutics
11.8.1 Opexa Therapeutics Company Information
11.8.2 Opexa Therapeutics Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
11.8.3 Opexa Therapeutics Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Opexa Therapeutics Main Business Overview
11.8.5 Opexa Therapeutics Latest Developments
11.9 TG Therapeutics
11.9.1 TG Therapeutics Company Information
11.9.2 TG Therapeutics Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
11.9.3 TG Therapeutics Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 TG Therapeutics Main Business Overview
11.9.5 TG Therapeutics Latest Developments
11.10 Bio-Thera Solutions
11.10.1 Bio-Thera Solutions Company Information
11.10.2 Bio-Thera Solutions Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
11.10.3 Bio-Thera Solutions Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Bio-Thera Solutions Main Business Overview
11.10.5 Bio-Thera Solutions Latest Developments
11.11 Boston Pharmaceuticals
11.11.1 Boston Pharmaceuticals Company Information
11.11.2 Boston Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
11.11.3 Boston Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Boston Pharmaceuticals Main Business Overview
11.11.5 Boston Pharmaceuticals Latest Developments
11.12 Cour Pharmaceutical
11.12.1 Cour Pharmaceutical Company Information
11.12.2 Cour Pharmaceutical Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
11.12.3 Cour Pharmaceutical Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Cour Pharmaceutical Main Business Overview
11.12.5 Cour Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2019-2030
2.1.2 Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Neuromyelitis Optica Spectrum Disorder (NMOSD) Segment by Type
2.2.1 Intravenous
2.2.2 Oral
2.2.3 Subcutaneous
2.2.4 Others
2.3 Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Type
2.3.1 Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Type (2019-2024)
2.4 Neuromyelitis Optica Spectrum Disorder (NMOSD) Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Application
2.5.1 Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Application (2019-2024)
3 NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD) MARKET SIZE BY PLAYER
3.1 Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Players
3.1.1 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue by Players (2019-2024)
3.1.2 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue Market Share by Players (2019-2024)
3.2 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD) BY REGIONS
4.1 Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Regions (2019-2024)
4.2 Americas Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth (2019-2024)
4.3 APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth (2019-2024)
4.4 Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth (2019-2024)
4.5 Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Country (2019-2024)
5.2 Americas Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Type (2019-2024)
5.3 Americas Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Region (2019-2024)
6.2 APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Type (2019-2024)
6.3 APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) by Country (2019-2024)
7.2 Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Type (2019-2024)
7.3 Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) by Region (2019-2024)
8.2 Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Type (2019-2024)
8.3 Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD) MARKET FORECAST
10.1 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Forecast by Regions (2025-2030)
10.1.1 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Forecast by Regions (2025-2030)
10.1.2 Americas Neuromyelitis Optica Spectrum Disorder (NMOSD) Forecast
10.1.3 APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Forecast
10.1.4 Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Forecast
10.1.5 Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Forecast
10.2 Americas Neuromyelitis Optica Spectrum Disorder (NMOSD) Forecast by Country (2025-2030)
10.2.1 United States Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.2.2 Canada Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.2.3 Mexico Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.2.4 Brazil Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.3 APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Forecast by Region (2025-2030)
10.3.1 China Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.3.2 Japan Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.3.3 Korea Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.3.4 Southeast Asia Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.3.5 India Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.3.6 Australia Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.4 Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Forecast by Country (2025-2030)
10.4.1 Germany Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.4.2 France Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.4.3 UK Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.4.4 Italy Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.4.5 Russia Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.5 Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Forecast by Region (2025-2030)
10.5.1 Egypt Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.5.2 South Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.5.3 Israel Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.5.4 Turkey Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.5.5 GCC Countries Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Forecast
10.6 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Forecast by Type (2025-2030)
10.7 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 F. Hoffmann-La Roche Ltd
11.1.1 F. Hoffmann-La Roche Ltd Company Information
11.1.2 F. Hoffmann-La Roche Ltd Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
11.1.3 F. Hoffmann-La Roche Ltd Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 F. Hoffmann-La Roche Ltd Main Business Overview
11.1.5 F. Hoffmann-La Roche Ltd Latest Developments
11.2 Alexion Pharmaceuticals
11.2.1 Alexion Pharmaceuticals Company Information
11.2.2 Alexion Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
11.2.3 Alexion Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Alexion Pharmaceuticals Main Business Overview
11.2.5 Alexion Pharmaceuticals Latest Developments
11.3 RemeGen
11.3.1 RemeGen Company Information
11.3.2 RemeGen Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
11.3.3 RemeGen Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 RemeGen Main Business Overview
11.3.5 RemeGen Latest Developments
11.4 Nihon Pharmaceutical
11.4.1 Nihon Pharmaceutical Company Information
11.4.2 Nihon Pharmaceutical Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
11.4.3 Nihon Pharmaceutical Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Nihon Pharmaceutical Main Business Overview
11.4.5 Nihon Pharmaceutical Latest Developments
11.5 Harbour BioMed
11.5.1 Harbour BioMed Company Information
11.5.2 Harbour BioMed Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
11.5.3 Harbour BioMed Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Harbour BioMed Main Business Overview
11.5.5 Harbour BioMed Latest Developments
11.6 Lundbeck
11.6.1 Lundbeck Company Information
11.6.2 Lundbeck Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
11.6.3 Lundbeck Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Lundbeck Main Business Overview
11.6.5 Lundbeck Latest Developments
11.7 Bionure
11.7.1 Bionure Company Information
11.7.2 Bionure Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
11.7.3 Bionure Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Bionure Main Business Overview
11.7.5 Bionure Latest Developments
11.8 Opexa Therapeutics
11.8.1 Opexa Therapeutics Company Information
11.8.2 Opexa Therapeutics Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
11.8.3 Opexa Therapeutics Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Opexa Therapeutics Main Business Overview
11.8.5 Opexa Therapeutics Latest Developments
11.9 TG Therapeutics
11.9.1 TG Therapeutics Company Information
11.9.2 TG Therapeutics Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
11.9.3 TG Therapeutics Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 TG Therapeutics Main Business Overview
11.9.5 TG Therapeutics Latest Developments
11.10 Bio-Thera Solutions
11.10.1 Bio-Thera Solutions Company Information
11.10.2 Bio-Thera Solutions Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
11.10.3 Bio-Thera Solutions Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Bio-Thera Solutions Main Business Overview
11.10.5 Bio-Thera Solutions Latest Developments
11.11 Boston Pharmaceuticals
11.11.1 Boston Pharmaceuticals Company Information
11.11.2 Boston Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
11.11.3 Boston Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Boston Pharmaceuticals Main Business Overview
11.11.5 Boston Pharmaceuticals Latest Developments
11.12 Cour Pharmaceutical
11.12.1 Cour Pharmaceutical Company Information
11.12.2 Cour Pharmaceutical Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
11.12.3 Cour Pharmaceutical Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Cour Pharmaceutical Main Business Overview
11.12.5 Cour Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Intravenous
Table 3. Major Players of Oral
Table 4. Major Players of Subcutaneous
Table 5. Major Players of Others
Table 6. Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Type (2019-2024)
Table 9. Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Application (2019-2024)
Table 12. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue Market Share by Player (2019-2024)
Table 14. Neuromyelitis Optica Spectrum Disorder (NMOSD) Key Players Head office and Products Offered
Table 15. Neuromyelitis Optica Spectrum Disorder (NMOSD) Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Regions (2019-2024)
Table 20. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Country (2019-2024)
Table 24. Americas Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Type (2019-2024)
Table 26. Americas Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Application (2019-2024)
Table 28. APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Region (2019-2024)
Table 30. APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Type (2019-2024)
Table 32. APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Application (2019-2024)
Table 34. Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Country (2019-2024)
Table 36. Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Type (2019-2024)
Table 38. Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Neuromyelitis Optica Spectrum Disorder (NMOSD)
Table 47. Key Market Challenges & Risks of Neuromyelitis Optica Spectrum Disorder (NMOSD)
Table 48. Key Industry Trends of Neuromyelitis Optica Spectrum Disorder (NMOSD)
Table 49. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. F. Hoffmann-La Roche Ltd Details, Company Type, Neuromyelitis Optica Spectrum Disorder (NMOSD) Area Served and Its Competitors
Table 54. F. Hoffmann-La Roche Ltd Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
Table 55. F. Hoffmann-La Roche Ltd Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. F. Hoffmann-La Roche Ltd Main Business
Table 57. F. Hoffmann-La Roche Ltd Latest Developments
Table 58. Alexion Pharmaceuticals Details, Company Type, Neuromyelitis Optica Spectrum Disorder (NMOSD) Area Served and Its Competitors
Table 59. Alexion Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
Table 60. Alexion Pharmaceuticals Main Business
Table 61. Alexion Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Alexion Pharmaceuticals Latest Developments
Table 63. RemeGen Details, Company Type, Neuromyelitis Optica Spectrum Disorder (NMOSD) Area Served and Its Competitors
Table 64. RemeGen Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
Table 65. RemeGen Main Business
Table 66. RemeGen Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. RemeGen Latest Developments
Table 68. Nihon Pharmaceutical Details, Company Type, Neuromyelitis Optica Spectrum Disorder (NMOSD) Area Served and Its Competitors
Table 69. Nihon Pharmaceutical Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
Table 70. Nihon Pharmaceutical Main Business
Table 71. Nihon Pharmaceutical Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Nihon Pharmaceutical Latest Developments
Table 73. Harbour BioMed Details, Company Type, Neuromyelitis Optica Spectrum Disorder (NMOSD) Area Served and Its Competitors
Table 74. Harbour BioMed Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
Table 75. Harbour BioMed Main Business
Table 76. Harbour BioMed Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Harbour BioMed Latest Developments
Table 78. Lundbeck Details, Company Type, Neuromyelitis Optica Spectrum Disorder (NMOSD) Area Served and Its Competitors
Table 79. Lundbeck Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
Table 80. Lundbeck Main Business
Table 81. Lundbeck Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Lundbeck Latest Developments
Table 83. Bionure Details, Company Type, Neuromyelitis Optica Spectrum Disorder (NMOSD) Area Served and Its Competitors
Table 84. Bionure Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
Table 85. Bionure Main Business
Table 86. Bionure Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Bionure Latest Developments
Table 88. Opexa Therapeutics Details, Company Type, Neuromyelitis Optica Spectrum Disorder (NMOSD) Area Served and Its Competitors
Table 89. Opexa Therapeutics Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
Table 90. Opexa Therapeutics Main Business
Table 91. Opexa Therapeutics Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Opexa Therapeutics Latest Developments
Table 93. TG Therapeutics Details, Company Type, Neuromyelitis Optica Spectrum Disorder (NMOSD) Area Served and Its Competitors
Table 94. TG Therapeutics Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
Table 95. TG Therapeutics Main Business
Table 96. TG Therapeutics Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. TG Therapeutics Latest Developments
Table 98. Bio-Thera Solutions Details, Company Type, Neuromyelitis Optica Spectrum Disorder (NMOSD) Area Served and Its Competitors
Table 99. Bio-Thera Solutions Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
Table 100. Bio-Thera Solutions Main Business
Table 101. Bio-Thera Solutions Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Bio-Thera Solutions Latest Developments
Table 103. Boston Pharmaceuticals Details, Company Type, Neuromyelitis Optica Spectrum Disorder (NMOSD) Area Served and Its Competitors
Table 104. Boston Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
Table 105. Boston Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Boston Pharmaceuticals Main Business
Table 107. Boston Pharmaceuticals Latest Developments
Table 108. Cour Pharmaceutical Details, Company Type, Neuromyelitis Optica Spectrum Disorder (NMOSD) Area Served and Its Competitors
Table 109. Cour Pharmaceutical Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
Table 110. Cour Pharmaceutical Main Business
Table 111. Cour Pharmaceutical Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. Cour Pharmaceutical Latest Developments
Table 1. Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Intravenous
Table 3. Major Players of Oral
Table 4. Major Players of Subcutaneous
Table 5. Major Players of Others
Table 6. Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Type (2019-2024)
Table 9. Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Application (2019-2024)
Table 12. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue Market Share by Player (2019-2024)
Table 14. Neuromyelitis Optica Spectrum Disorder (NMOSD) Key Players Head office and Products Offered
Table 15. Neuromyelitis Optica Spectrum Disorder (NMOSD) Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Regions (2019-2024)
Table 20. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Country (2019-2024)
Table 24. Americas Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Type (2019-2024)
Table 26. Americas Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Application (2019-2024)
Table 28. APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Region (2019-2024)
Table 30. APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Type (2019-2024)
Table 32. APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Application (2019-2024)
Table 34. Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Country (2019-2024)
Table 36. Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Type (2019-2024)
Table 38. Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Neuromyelitis Optica Spectrum Disorder (NMOSD)
Table 47. Key Market Challenges & Risks of Neuromyelitis Optica Spectrum Disorder (NMOSD)
Table 48. Key Industry Trends of Neuromyelitis Optica Spectrum Disorder (NMOSD)
Table 49. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. F. Hoffmann-La Roche Ltd Details, Company Type, Neuromyelitis Optica Spectrum Disorder (NMOSD) Area Served and Its Competitors
Table 54. F. Hoffmann-La Roche Ltd Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
Table 55. F. Hoffmann-La Roche Ltd Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. F. Hoffmann-La Roche Ltd Main Business
Table 57. F. Hoffmann-La Roche Ltd Latest Developments
Table 58. Alexion Pharmaceuticals Details, Company Type, Neuromyelitis Optica Spectrum Disorder (NMOSD) Area Served and Its Competitors
Table 59. Alexion Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
Table 60. Alexion Pharmaceuticals Main Business
Table 61. Alexion Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Alexion Pharmaceuticals Latest Developments
Table 63. RemeGen Details, Company Type, Neuromyelitis Optica Spectrum Disorder (NMOSD) Area Served and Its Competitors
Table 64. RemeGen Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
Table 65. RemeGen Main Business
Table 66. RemeGen Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. RemeGen Latest Developments
Table 68. Nihon Pharmaceutical Details, Company Type, Neuromyelitis Optica Spectrum Disorder (NMOSD) Area Served and Its Competitors
Table 69. Nihon Pharmaceutical Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
Table 70. Nihon Pharmaceutical Main Business
Table 71. Nihon Pharmaceutical Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Nihon Pharmaceutical Latest Developments
Table 73. Harbour BioMed Details, Company Type, Neuromyelitis Optica Spectrum Disorder (NMOSD) Area Served and Its Competitors
Table 74. Harbour BioMed Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
Table 75. Harbour BioMed Main Business
Table 76. Harbour BioMed Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Harbour BioMed Latest Developments
Table 78. Lundbeck Details, Company Type, Neuromyelitis Optica Spectrum Disorder (NMOSD) Area Served and Its Competitors
Table 79. Lundbeck Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
Table 80. Lundbeck Main Business
Table 81. Lundbeck Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Lundbeck Latest Developments
Table 83. Bionure Details, Company Type, Neuromyelitis Optica Spectrum Disorder (NMOSD) Area Served and Its Competitors
Table 84. Bionure Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
Table 85. Bionure Main Business
Table 86. Bionure Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Bionure Latest Developments
Table 88. Opexa Therapeutics Details, Company Type, Neuromyelitis Optica Spectrum Disorder (NMOSD) Area Served and Its Competitors
Table 89. Opexa Therapeutics Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
Table 90. Opexa Therapeutics Main Business
Table 91. Opexa Therapeutics Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Opexa Therapeutics Latest Developments
Table 93. TG Therapeutics Details, Company Type, Neuromyelitis Optica Spectrum Disorder (NMOSD) Area Served and Its Competitors
Table 94. TG Therapeutics Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
Table 95. TG Therapeutics Main Business
Table 96. TG Therapeutics Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. TG Therapeutics Latest Developments
Table 98. Bio-Thera Solutions Details, Company Type, Neuromyelitis Optica Spectrum Disorder (NMOSD) Area Served and Its Competitors
Table 99. Bio-Thera Solutions Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
Table 100. Bio-Thera Solutions Main Business
Table 101. Bio-Thera Solutions Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Bio-Thera Solutions Latest Developments
Table 103. Boston Pharmaceuticals Details, Company Type, Neuromyelitis Optica Spectrum Disorder (NMOSD) Area Served and Its Competitors
Table 104. Boston Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
Table 105. Boston Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Boston Pharmaceuticals Main Business
Table 107. Boston Pharmaceuticals Latest Developments
Table 108. Cour Pharmaceutical Details, Company Type, Neuromyelitis Optica Spectrum Disorder (NMOSD) Area Served and Its Competitors
Table 109. Cour Pharmaceutical Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Offered
Table 110. Cour Pharmaceutical Main Business
Table 111. Cour Pharmaceutical Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. Cour Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Neuromyelitis Optica Spectrum Disorder (NMOSD) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Market Share by Country/Region (2023)
Figure 8. Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Type in 2023
Figure 10. Neuromyelitis Optica Spectrum Disorder (NMOSD) in Hospital
Figure 11. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market: Hospital (2019-2024) & ($ Millions)
Figure 12. Neuromyelitis Optica Spectrum Disorder (NMOSD) in Clinic
Figure 13. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market: Clinic (2019-2024) & ($ Millions)
Figure 14. Neuromyelitis Optica Spectrum Disorder (NMOSD) in Others
Figure 15. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Application in 2023
Figure 17. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue Market Share by Player in 2023
Figure 18. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2019-2024 ($ Millions)
Figure 20. APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2019-2024 ($ Millions)
Figure 21. Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2019-2024 ($ Millions)
Figure 23. Americas Neuromyelitis Optica Spectrum Disorder (NMOSD) Value Market Share by Country in 2023
Figure 24. United States Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Region in 2023
Figure 29. APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Type in 2023
Figure 30. APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Application in 2023
Figure 31. China Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Country in 2023
Figure 38. Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Type (2019-2024)
Figure 39. Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Application (2019-2024)
Figure 40. Germany Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 54. APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 55. Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 57. United States Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 58. Canada Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 61. China Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 62. Japan Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 63. Korea Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 65. India Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 66. Australia Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 67. Germany Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 68. France Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 69. UK Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 70. Italy Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 71. Russia Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 72. Spain Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 75. Israel Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 78. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Neuromyelitis Optica Spectrum Disorder (NMOSD) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Market Share by Country/Region (2023)
Figure 8. Neuromyelitis Optica Spectrum Disorder (NMOSD) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Type in 2023
Figure 10. Neuromyelitis Optica Spectrum Disorder (NMOSD) in Hospital
Figure 11. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market: Hospital (2019-2024) & ($ Millions)
Figure 12. Neuromyelitis Optica Spectrum Disorder (NMOSD) in Clinic
Figure 13. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market: Clinic (2019-2024) & ($ Millions)
Figure 14. Neuromyelitis Optica Spectrum Disorder (NMOSD) in Others
Figure 15. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Application in 2023
Figure 17. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue Market Share by Player in 2023
Figure 18. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2019-2024 ($ Millions)
Figure 20. APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2019-2024 ($ Millions)
Figure 21. Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2019-2024 ($ Millions)
Figure 23. Americas Neuromyelitis Optica Spectrum Disorder (NMOSD) Value Market Share by Country in 2023
Figure 24. United States Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Region in 2023
Figure 29. APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Type in 2023
Figure 30. APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Application in 2023
Figure 31. China Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Country in 2023
Figure 38. Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Type (2019-2024)
Figure 39. Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Application (2019-2024)
Figure 40. Germany Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 54. APAC Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 55. Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 57. United States Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 58. Canada Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 61. China Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 62. Japan Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 63. Korea Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 65. India Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 66. Australia Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 67. Germany Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 68. France Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 69. UK Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 70. Italy Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 71. Russia Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 72. Spain Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 75. Israel Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size 2025-2030 ($ Millions)
Figure 78. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Market Share Forecast by Application (2025-2030)
